Lantheus Holdings Stock Underperforms Despite Strong Earnings Growth
-
Lantheus Holdings (LNTH) stock has underperformed recently, returning -13% over the past month versus the S&P 500's +5.3%. However, the medical products industry has gained 6%.
-
Earnings estimate revisions are closely watched as indicators of future stock performance. For LNTH, the Zacks consensus EPS estimate for the current quarter has increased 1.2% to $1.36 over the last 30 days.
-
The consensus revenue estimate for LNTH of $326.74 million for the current quarter points to impressive year-over-year growth of 24.2%. Full year revenue growth is estimated at 35.7%.
-
LNTH reported strong 33.7% year-over-year revenue growth last quarter to $319.95 million, beating estimates by 1.57%. EPS also exceeded expectations.
-
LNTH has a Zacks Rank #3 (Hold), indicating it may perform in line with the broader market. Valuation grades show the stock is fairly valued relative to industry peers.